Why Charles River (CRL) Is Up 5.8% After Divesting Units And Refreshing Its Leadership Team [Yahoo! Finance]
Charles River Laboratories International, Inc. (CRL)
Last charles river laboratories international, inc. earnings: 2/11 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.criver.com
Company Research
Source: Yahoo! Finance
Coleman as Executive Vice President and Chief Financial Officer and Kerry Dailey as Senior Vice President and Chief Legal Officer. Together, these portfolio changes and leadership appointments suggest the company is reshaping its business mix and governance to sharpen operational focus and oversight. Next, we will examine how shedding the CDMO and Cell Solutions businesses could influence Charles River's existing investment narrative and risk profile. We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them. Charles River Laboratories International Investment Narrative Recap To own Charles River Laboratories, you generally need to believe that its contract research and safety assessment services remain central to global drug development, even as testing methods evolve and biotech funding cycles ebb and flow. The planned sale of its CDMO and Cell Solutions units looks material for the near term, because it could simplif
Show less
Read more
Impact Snapshot
Event Time:
CRL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRL alerts
High impacting Charles River Laboratories International, Inc. news events
Weekly update
A roundup of the hottest topics
CRL
News
- Charles River Laboratories Schedules First-Quarter 2026 Earnings Release and Conference CallBusiness Wire
- Charles River Laboratories International (CRL) had its "overweight" rating reaffirmed by Barclays PLC.MarketBeat
- Charles River Laboratories International (CRL) is now covered by Royal Bank Of Canada. They set an "outperform" rating on the stock.MarketBeat
- Charles River Laboratories International (CRL) had its price target lowered by JPMorgan Chase & Co. from $165.00 to $160.00. They now have a "neutral" rating on the stock.MarketBeat
- Charles River Laboratories International (CRL) had its "outperform" rating reaffirmed by Evercore Inc.MarketBeat
CRL
Earnings
- 2/18/26 - Beat
CRL
Sec Filings
- 4/8/26 - Form 3
- 3/31/26 - Form ARS
- 3/31/26 - Form DEF
- CRL's page on the SEC website